Enovis (ENOV)

NYSE Health Care Health Care Equipment S&P SmallCap 600
$27.16
-1.46 (-5.10%)
Close of Nov 06, 2026 · end-of-day data
Source: Enovis's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$3.19B$1.94B$2.19B$3.33B$1.12B$1.43B$1.56B$1.71B$2.11B$2.25B
Cost of revenue$2.19B$1.27B$1.46B$1.93B$517.06M$648.51M$693.72M$716.42M$926.87M$902.79M
Gross profit$992.38M$671.58M$729.38M$1.40B$603.64M$777.67M$869.38M$990.78M$1.18B$1.35B
Research & development————$34.27M$49.09M$60.83M$75.33M$91.30M$120.33M
Selling, general & admin$696.80M$500.65M$548.76M$1.13B$515.47M$665.77M$772.91M$830.30M$1.03B$1.07B
Operating income$236.85M$135.60M$151.54M$203.61M-$66.18M-$62.80M-$71.18M-$65.71M-$775.72M-$1.12B
Interest expense$30.28M$40.11M$49.08M$119.50M$52.82M$29.11M$24.05M$19.75M$57.10M$34.82M
Pre-tax income$206.52M$48.56M$92.36M$50.49M-$119.01M-$121.78M-$2.07M-$67.13M-$822.92M-$1.16B
Income tax$51.77M$2.48M-$29.51M$31.63M-$44.58M-$19.53M$36.12M-$13.29M$4.49M$22.29M
Net income$128.11M$151.09M$140.20M-$527.65M$42.62M$71.66M-$13.29M-$33.26M-$825.49M-$1.18B
EBITDA$365.68M$208.29M$232.74M$419.22M$101.72M$124.19M$131.79M$151.40M$152.11M$219.89M
EPS (basic)$1.04$1.23$1.17$-3.89$0.93$1.40$-0.25$-0.61$-14.93$-20.75
EPS (diluted)$1.04$1.22$1.16$-3.89$0.93$1.40$-0.25$-0.61$-14.93$-20.75
Diluted shares123.20M124.00M120.80M136.67M45.59M51.14M54.07M54.49M55.28M57.07M
Gross margin31.2%34.7%33.3%42.1%53.9%54.5%55.6%58.0%56.0%59.8%
Operating margin7.4%7.0%6.9%6.1%-5.9%-4.4%-4.6%-3.8%-36.8%-50.0%
Net margin4.0%7.8%6.4%-15.9%3.8%5.0%-0.9%-1.9%-39.2%-52.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$208.81M$262.02M$77.15M$109.63M$97.07M$680.25M$24.30M$36.19M$48.17M$36.39M
Short-term investments$0$149.61M$0———————
Receivables$838.80M$970.20M$386.59M$561.87M$517.01M$254.96M$267.38M$291.48M$407.03M$442.79M
Inventory$364.97M$429.63M$359.65M$571.56M$564.82M$356.23M$426.64M$468.83M$547.12M$584.38M
Total current assets$1.74B$2.07B$1.96B$1.40B$1.36B$2.30B$795.02M$896.52M$1.15B$1.21B
Goodwill$2.35B$1.43B$1.50B$3.20B$1.76B$1.93B$1.98B$2.06B$1.69B$718.30M
Total assets$6.34B$6.71B$6.62B$7.39B$7.35B$8.52B$4.27B$4.51B$4.72B$3.83B
Total current liabilities$1.06B$1.10B$1.20B$857.31M$811.66M$1.02B$565.20M$369.61M$529.00M$598.47M
Short-term debt$5.41M$5.77M$5.02M$27.64M$27.07M$7.70M$219.28M$0$20.03M$35.00M
Long-term debt$1.29B$1.06B$1.19B$2.28B$2.20B$2.08B$40.00M$466.16M$1.31B$1.26B
Total debt$1.29B$1.06B$1.20B$2.31B$2.23B$2.09B$259.28M$466.16M$1.33B$1.30B
Total liabilities$3.25B$2.98B$3.14B$3.90B$3.76B$3.85B$823.45M$1.09B$2.15B$2.34B
Shareholders' equity$2.90B$3.50B$3.27B$3.44B$3.54B$4.62B$3.45B$3.42B$2.56B$1.49B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$246.97M$218.77M$226.37M$130.95M$301.94M$356.10M-$55.86M$134.99M$113.50M$217.29M
Capital expenditures$63.25M$68.77M$69.65M$125.40M$114.78M$104.24M$105.45M$122.22M$180.71M$197.38M
Free cash flow$183.72M$150.00M$156.72M$5.55M$187.15M$251.86M-$161.31M$12.77M-$67.21M$19.92M
Investing cash flow-$81.99M$89.88M-$167.85M-$1.63B-$175.08M-$320.48M-$176.39M-$242.47M-$955.47M-$179.37M
Financing cash flow-$145.22M-$280.45M-$47.15M$1.37B-$131.65M$584.91M-$465.13M$127.80M$846.82M-$52.40M
Share buybacks$20.81M$0$200.00M$0$0—$0$0$4.77M$3.50M
Stock-based compensation$19.02M$21.55M$25.10M$21.96M$28.91M$35.35M$38.95M$34.06M$29.66M$32.92M
Depreciation & amortization$128.83M$72.69M$81.21M$215.61M$167.90M$186.99M$202.97M$217.11M$927.83M$1.34B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.